Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Myeloma Bispecific Antibody Research

Katja Weisel

MD

🏢University Medical Center Hamburg-Eppendorf🌐Germany

Professor of Medicine, Head of Myeloma Program

48
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Katja Weisel is a leading German myeloma researcher who has led GMMG group trials and evaluated bispecific antibodies across treatment lines. Her research on quality of life and patient-reported outcomes with novel immunotherapies has enriched clinical trial endpoints. She contributes to European guidelines on sequencing bispecifics and CAR-T cells.

Share:

🧪Research Fields 研究领域

Bispecific antibody sequencing
GMMG trials
Myeloma quality of life
CAR-T vs bispecific
German myeloma network

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Katja Weisel 的研究动态

Follow Katja Weisel's research updates

留下邮箱,当我们发布与 Katja Weisel(University Medical Center Hamburg-Eppendorf)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment